Finance

Lists
ACL:ASX
Australian Clinical Labs Ltd
A$2.78
+0.36%
(+0.0100) 1D
Sep 28, 4:10:27 PM GMT+10  ·   AUD
All symbols
SymbolPriceChange% Change
Generating top insights for ACL...
Open
A$2.84
High
A$2.84
Low
A$2.74
Mkt. cap
518.52M
Avg. vol.
898.89K
Volume
163.76K
Dividend
4.68%
Quarterly dividend
A$0.03
Ex-dividend date
Sep 2, 2026
P/E ratio
22.55
52-wk high
A$3.03
52-wk low
A$1.83
EPS
A$0.12
Shares outstanding
186.52M
No. of employees
4K
Open
A$2.84
High
A$2.84
Low
A$2.74
Mkt. cap
518.52M
Avg. vol.
898.89K
Volume
163.76K
Dividend
4.68%
Quarterly dividend
A$0.03
Ex-dividend date
Sep 2, 2026
P/E ratio
22.55
52-wk high
A$3.03
52-wk low
A$1.83
EPS
A$0.12
Shares outstanding
186.52M
No. of employees
4K
About Australian Clinical Labs Ltd
CEO-
Employees4.5K
Founded2015
Headquarters-
SectorHealth care provider
Websiteclinicallabs.com.au
Previous reportsAll values in AUD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in AUD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
182.70M
182.70M
185.38M
185.38M
Cost of goods sold
118.21M
118.21M
109.53M
109.53M
Cost of revenue
118.21M
118.21M
109.53M
109.53M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
-
-
4.83M
4.83M
Operating expense
50.51M
50.51M
55.05M
55.05M
Total operating expenses
168.72M
168.72M
164.58M
164.58M
Operating income
13.98M
13.98M
20.80M
20.80M
Other non operating income
-829.50K
-829.50K
-1.06M
-1.06M
EBT including unusual items
5.60M
5.60M
13.10M
13.10M
EBT excluding unusual items
9.72M
9.72M
16.03M
16.03M
Income tax expense
2.74M
2.74M
3.95M
3.95M
Effective tax rate
48.91%
48.91%
30.15%
30.15%
Other operating expenses
17.16M
17.16M
15.90M
15.90M
Net income
2.78M
2.78M
9.07M
9.07M
Net profit margin
1.52%
1.52%
4.89%
4.89%
Earnings per share
-
-
-
-
Interest and investment income
92.00K
92.00K
96.00K
96.00K
Interest expense
-3.53M
-3.53M
-3.81M
-3.81M
Net interest expenses
-3.43M
-3.43M
-3.72M
-3.72M
Depreciation and amortization charges
33.29M
33.29M
34.26M
34.26M
EBITDA
17.19M
17.19M
23.75M
23.75M
Gain or loss from assets sale
-
-
-36.00K
-36.00K
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps